Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

Accounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...

LOS ANGELES — Topography-guided laser vision correction offers several benefits: It is not dependent on pupil size, can be ...

PRO, but as the rules are new for January 2025, the exact coverage details, including out-of-pocket costs, are unclear. Read more.

Psychiatric neurosurgery, originally known as psychosurgery, involves operating on the brain to alter its function. Nastasic ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

Technologies has filed its 510(k) submission to the FDA for trigeminal nerve ablation earlier than previous guidance.

NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.